Riot Blockchain Inc (RIOT) Company Profile

Riot Blockchain Inc Company Snapshot

Riot Blockchain Inc operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Riot Blockchain Inc with three other companies in this sector in UNITED STATES : ImmuCell Corporation (2020 sales of $15.34 million of which 98% was First Defense product line), Celldex Therapeutics, Incorporation ($7.42 million of which 100% was Novel Therapeutics), and Aspira Women's Health Inc ($4.65 million of which 100% was Novel Diagnostic Test).

Sales Analysis. During the year ended December of 2020, sales at Riot Blockchain Inc were $12.08 million. This is an increase of 76.7% versus 2019, when the company's sales were $6.84 million.

Riot Blockchain Inc

Stock Data:

Recent Stock Performance:

Current Price (5/14/2021): 26.02
(Figures in U.S. Dollars)

1 Week	-22.1%	13 Weeks	-41.7%

4 Weeks	-47.2%	52 Weeks	1,151.0%

Riot Blockchain Inc Key Data:

Ticker:	RIOT	Country:	United States

Exchanges:	NAS	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Diagnostic Substances

2020 Sales	12,081,000 (Year Ending Jan 2021).	Employees:	8

Currency:	U.S. Dollars	Market Cap:	2,043,181,912

Fiscal Yr Ends:	December	Shares Outstanding:	78,523,517

Share Type:	Common	Closely Held Shares:	2,015,871

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.